Viridian Therapeutics Stock Technical Analysis
| VRDN Stock | USD 21.87 0.04 0.18% |
As of the 28th of November, Viridian Therapeutics has the Coefficient Of Variation of 759.95, semi deviation of 3.44, and Risk Adjusted Performance of 0.1094. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viridian Therapeutics, as well as the relationship between them.
Viridian Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Viridian, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ViridianViridian |
Viridian Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 43.53 | Strong Buy | 16 | Odds |
Most Viridian analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Viridian stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Viridian Therapeutics, talking to its executives and customers, or listening to Viridian conference calls.
Viridian Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Viridian Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Viridian Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Viridian Therapeutics Trend Analysis
Use this graph to draw trend lines for Viridian Therapeutics. You can use it to identify possible trend reversals for Viridian Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Viridian Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Viridian Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Viridian Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.04 , which means Viridian Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 58.97, which is the sum of squared deviations for the predicted Viridian Therapeutics price change compared to its average price change.About Viridian Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Viridian Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Viridian Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Viridian Therapeutics price pattern first instead of the macroeconomic environment surrounding Viridian Therapeutics. By analyzing Viridian Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Viridian Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Viridian Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Dividend Yield | 8.52E-4 | 0.001448 | Price To Sales Ratio | 3.1K | 3.3K |
Viridian Therapeutics November 28, 2024 Technical Indicators
Most technical analysis of Viridian help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Viridian from various momentum indicators to cycle indicators. When you analyze Viridian charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1094 | |||
| Market Risk Adjusted Performance | 0.3833 | |||
| Mean Deviation | 3.19 | |||
| Semi Deviation | 3.44 | |||
| Downside Deviation | 3.82 | |||
| Coefficient Of Variation | 759.95 | |||
| Standard Deviation | 5.35 | |||
| Variance | 28.64 | |||
| Information Ratio | 0.1082 | |||
| Jensen Alpha | 0.4797 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.1514 | |||
| Treynor Ratio | 0.3733 | |||
| Maximum Drawdown | 44.89 | |||
| Value At Risk | (5.29) | |||
| Potential Upside | 6.84 | |||
| Downside Variance | 14.62 | |||
| Semi Variance | 11.82 | |||
| Expected Short fall | (3.75) | |||
| Skewness | 2.88 | |||
| Kurtosis | 18.14 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Viridian Stock, please use our How to Invest in Viridian Therapeutics guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viridian Therapeutics. If investors know Viridian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viridian Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.32) | Revenue Per Share 0.005 | Quarterly Revenue Growth 0.194 | Return On Assets (0.32) | Return On Equity (0.52) |
The market value of Viridian Therapeutics is measured differently than its book value, which is the value of Viridian that is recorded on the company's balance sheet. Investors also form their own opinion of Viridian Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viridian Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viridian Therapeutics' market value can be influenced by many factors that don't directly affect Viridian Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viridian Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viridian Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viridian Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.